PD173074

CAS No. 219580-11-7

PD173074( PD173074 | PD 173074 | PD-173074 )

Catalog No. M13497 CAS No. 219580-11-7

PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM in cell-free assays, ~1000-fold selective for FGFR1 than PDGFR and c-Src.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 51 In Stock
5MG 34 In Stock
10MG 49 In Stock
25MG 86 In Stock
50MG 133 In Stock
100MG 217 In Stock
200MG 384 In Stock
500MG 641 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PD173074
  • Note
    Research use only, not for human use.
  • Brief Description
    PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM in cell-free assays, ~1000-fold selective for FGFR1 than PDGFR and c-Src.
  • Description
    PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM in cell-free assays, ~1000-fold selective for FGFR1 than PDGFR and c-Src.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PD173074 | PD 173074 | PD-173074
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR| FGFR1| Insulin Receptor| c-Src| VEGFR2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    219580-11-7
  • Formula Weight
    523.67
  • Molecular Formula
    C28H41N7O3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 100 mg/mL (190.95 mM); DMSO: 100 mg/mL (190.95 mM)
  • SMILES
    O=C(NC1=NC2=NC(NCCCCN(CC)CC)=NC=C2C=C1C3=CC(OC)=CC(OC)=C3)NC(C)(C)C
  • Chemical Name
    1-(tert-butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mohammadi M, et al. EMBO J, 1998, 17(20), 5896-5904.
molnova catalog
related products
  • (1R,2R)-Trans-N-Boc-...

    Cyclohexanediamine has a potential of anticancer activity.

  • AG-825

    AG-825(Tyrphostin C15) is a selective and competitive ErbB2 inhibitor that inhibits tyrosine phosphorylation with an IC50 value of 0.35 μM.AG-825 (Tyrphostin C15) inhibits HER2 and shows anticancer activity in a mouse xenograft model of breast cancer.

  • WHI-P258

    WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.